Clinical outcomes
| All patients N=100 | Solumbra group N=55 (%) | ADAPT group N=45 (%) | p Value* | |
|---|---|---|---|---|
| Any post-thrombectomy ICH | 36 | 26 (47) | 10 (22) | 0.01 |
| Any post-thrombectomy SAH | 16 | 13 (24) | 3 (7) | 0.03 |
| Post-thrombectomy SICH | 8 | 7 (13) | 1 (2) | 0.07 |
| Intraparenchymal | 3 | 2 (4) | 1 (2) | 1 |
| Subarachnoid | 5 | 5 (9) | 0 | 0.06 |
| Mean Neuro-ICU LOS, days | 3.1 | 3.7 | 2.4 | 0.04 |
| Mean hospital LOS, days | 6.5 | 6.8 | 6.2 | 0.5 |
| Discharge disposition | ||||
| Home | 19 | 8 (15) | 11 (24) | 0.3 |
| Rehabilitation | 43 | 22 (40) | 21 (47) | 0.5 |
| SNF | 16 | 9 (16) | 7 (16) | 1 |
| Expired/hospice | 22 | 16 (29) | 6 (13) | 0.09 |
| 90-day mortality | 24 | 16 (29) | 8 (18) | 0.24 |
| Good clinical outcome at 90 days (mRS 0–2) | 42 | 17 (31) | 25 (56) | 0.015 |
Bold type indicates statistical significance.
*p Value for the difference between the Solumbra group and the ADAPT group using either the Student t test or Fisher exact test.
ADAPT, A Direct Aspiration first-Pass Thrombectomy; ICH, intracranial hemorrhage; ICU, intensive care unit; LOS, length of stay; mRS, modified Rankin Scale; N, number of patients; SAH, subarachnoid hemorrhage; SICH, symptomatic intracranial hemorrhage according to SITS-MOST criteria; SNF, skilled nursing facility.